Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Valentina, Bonev"'
Autor:
Valentina Bonev
Publikováno v:
Nutrition and Food Science International Journal. 11
Breast pain, also known as mastalgia or mastodynia, is a common symptom that affects 70% of women during their lifetime [1]. It can impact quality of life and cause anxiety and distress for the patient [2]. Patients are most concerned about breast ca
Autor:
Valentina, Bonev, Carlos Chavez, De Paz Villanueva, Naveenraj, Solomon, Maheswari, Senthil, Mark E, Reeves, Carlos, Garberoglio, Sharon S, Lum
Publikováno v:
The American surgeon. 82(10)
When ductal carcinoma in situ (DCIS) is found on core needle biopsy, rates of upgrade to invasive cancer of 25 per cent and nodal positivity of 10 per cent have been reported. Sentinel lymph node dissection (SLND) is recommended when mastectomy is pe
Factors Associated With Underestimation of Invasive Cancer in Patients With Ductal Carcinoma In Situ
Autor:
Carlos A. Garberoglio, Valentina Bonev, Maheswari Senthil, Naveenraj L. Solomon, Carlos Chavez de Paz Villanueva, Sharon S. Lum, Jukes P. Namm, Mark E. Reeves
Publikováno v:
JAMA Surgery. 152:1007
Importance Recent recognition of the overdiagnosis and overtreatment of ductal carcinoma in situ (DCIS) detected by mammography has led to the development of clinical trials randomizing women with non–high-grade DCIS to active surveillance, defined
Autor:
David Hsiang, Min-Ying Su, Rita S. Mehta, John Butler, Maristella Evangelista, Karen T. Lane, Jeon-Hor Chen, Valentina Bonev
Publikováno v:
The American surgeon, vol 80, iss 10
Bonev, V; Evangelista, M; Chen, JH; Su, MY; Lane, K; Mehta, R; et al.(2014). Long-term follow-up of breast-conserving therapy in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy. American Surgeon, 80(10), 940-943. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/13c445xq
Bonev, V; Evangelista, M; Chen, JH; Su, MY; Lane, K; Mehta, R; et al.(2014). Long-term follow-up of breast-conserving therapy in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy. American Surgeon, 80(10), 940-943. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/13c445xq
© 2014, Southeastern Surgical Congress. All rights reserved. Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer. Currently, multimodality treatment is recommended, but the optimal surgical management has not been fully e